Logo image of TR1.DE

T ROWE PRICE GROUP INC (TR1.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:TR1 - US74144T1088 - Common Stock

90.42 EUR
-2.7 (-2.9%)
Last: 1/7/2026, 7:00:00 PM
Fundamental Rating

7

TR1 gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 120 industry peers in the Capital Markets industry. TR1 has an excellent financial health rating, but there are some minor concerns on its profitability. TR1 may be a bit undervalued, certainly considering the very reasonable score on growth Finally TR1 also has an excellent dividend rating. These ratings could make TR1 a good candidate for value and dividend investing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year TR1 was profitable.
In the past year TR1 had a positive cash flow from operations.
In the past 5 years TR1 has always been profitable.
TR1 had a positive operating cash flow in each of the past 5 years.
TR1.DE Yearly Net Income VS EBIT VS OCF VS FCFTR1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

With an excellent Return On Assets value of 13.79%, TR1 belongs to the best of the industry, outperforming 94.17% of the companies in the same industry.
Looking at the Return On Equity, with a value of 18.78%, TR1 is in the better half of the industry, outperforming 78.33% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 13.51%, TR1 belongs to the top of the industry, outperforming 92.50% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for TR1 is significantly above the industry average of 8.64%.
Industry RankSector Rank
ROA 13.79%
ROE 18.78%
ROIC 13.51%
ROA(3y)14.15%
ROA(5y)17.62%
ROE(3y)18.44%
ROE(5y)23.71%
ROIC(3y)15.27%
ROIC(5y)18%
TR1.DE Yearly ROA, ROE, ROICTR1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

With a decent Profit Margin value of 28.18%, TR1 is doing good in the industry, outperforming 76.67% of the companies in the same industry.
TR1's Profit Margin has declined in the last couple of years.
The Operating Margin of TR1 (32.91%) is better than 75.00% of its industry peers.
In the last couple of years the Operating Margin of TR1 has declined.
Industry RankSector Rank
OM 32.91%
PM (TTM) 28.18%
GM N/A
OM growth 3Y-11.5%
OM growth 5Y-4.63%
PM growth 3Y-9.7%
PM growth 5Y-4.85%
GM growth 3YN/A
GM growth 5YN/A
TR1.DE Yearly Profit, Operating, Gross MarginsTR1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

9

2. Health

2.1 Basic Checks

TR1 has less shares outstanding than it did 1 year ago.
TR1 has less shares outstanding than it did 5 years ago.
The debt/assets ratio for TR1 has been reduced compared to a year ago.
TR1.DE Yearly Shares OutstandingTR1.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
TR1.DE Yearly Total Debt VS Total AssetsTR1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

TR1 has an Altman-Z score of 5.81. This indicates that TR1 is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of TR1 (5.81) is better than 92.50% of its industry peers.
TR1 has a debt to FCF ratio of 0.03. This is a very positive value and a sign of high solvency as it would only need 0.03 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.03, TR1 belongs to the best of the industry, outperforming 98.33% of the companies in the same industry.
A Debt/Equity ratio of 0.00 indicates that TR1 is not too dependend on debt financing.
The Debt to Equity ratio of TR1 (0.00) is better than 90.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.03
Altman-Z 5.81
ROIC/WACCN/A
WACCN/A
TR1.DE Yearly LT Debt VS Equity VS FCFTR1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

TR1 has a Current Ratio of 2.76. This indicates that TR1 is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.76, TR1 belongs to the top of the industry, outperforming 86.67% of the companies in the same industry.
TR1 has a Quick Ratio of 2.76. This indicates that TR1 is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.76, TR1 belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.76
Quick Ratio 2.76
TR1.DE Yearly Current Assets VS Current LiabilitesTR1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 5.26% over the past year.
Measured over the past 5 years, TR1 shows a small growth in Earnings Per Share. The EPS has been growing by 2.42% on average per year.
The Revenue has been growing slightly by 4.26% in the past year.
TR1 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.78% yearly.
EPS 1Y (TTM)5.26%
EPS 3Y-9.91%
EPS 5Y2.42%
EPS Q2Q%9.34%
Revenue 1Y (TTM)4.26%
Revenue growth 3Y-2.58%
Revenue growth 5Y4.78%
Sales Q2Q%6.04%

3.2 Future

TR1 is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.23% yearly.
Based on estimates for the next years, TR1 will show a small growth in Revenue. The Revenue will grow by 1.47% on average per year.
EPS Next Y6.35%
EPS Next 2Y5.83%
EPS Next 3Y3.92%
EPS Next 5Y4.23%
Revenue Next Year2.74%
Revenue Next 2Y4.16%
Revenue Next 3Y3.44%
Revenue Next 5Y1.47%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TR1.DE Yearly Revenue VS EstimatesTR1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B
TR1.DE Yearly EPS VS EstimatesTR1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2 4 6 8 10

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 11.23 indicates a reasonable valuation of TR1.
82.50% of the companies in the same industry are more expensive than TR1, based on the Price/Earnings ratio.
TR1's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.00.
TR1 is valuated reasonably with a Price/Forward Earnings ratio of 10.10.
Based on the Price/Forward Earnings ratio, TR1 is valued cheaply inside the industry as 89.17% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 23.70. TR1 is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.23
Fwd PE 10.1
TR1.DE Price Earnings VS Forward Price EarningsTR1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, TR1 is valued cheaper than 85.00% of the companies in the same industry.
TR1's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. TR1 is cheaper than 75.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.7
EV/EBITDA 7.35
TR1.DE Per share dataTR1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
TR1 has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.77
PEG (5Y)4.65
EPS Next 2Y5.83%
EPS Next 3Y3.92%

7

5. Dividend

5.1 Amount

TR1 has a Yearly Dividend Yield of 4.96%, which is a nice return.
TR1's Dividend Yield is rather good when compared to the industry average which is at 3.25. TR1 pays more dividend than 81.67% of the companies in the same industry.
TR1's Dividend Yield is rather good when compared to the S&P500 average which is at 1.94.
Industry RankSector Rank
Dividend Yield 4.96%

5.2 History

On average, the dividend of TR1 grows each year by 10.37%, which is quite nice.
Dividend Growth(5Y)10.37%
Div Incr Years2
Div Non Decr Years2
TR1.DE Yearly Dividends per shareTR1.DE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

56.29% of the earnings are spent on dividend by TR1. This is a bit on the high side, but may be sustainable.
TR1's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP56.29%
EPS Next 2Y5.83%
EPS Next 3Y3.92%
TR1.DE Yearly Income VS Free CF VS DividendTR1.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
TR1.DE Dividend Payout.TR1.DE Dividend Payout, showing the Payout Ratio.TR1.DE Dividend Payout.PayoutRetained Earnings

T ROWE PRICE GROUP INC

FRA:TR1 (1/7/2026, 7:00:00 PM)

90.42

-2.7 (-2.9%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)10-31 2025-10-31/bmo
Earnings (Next)01-22 2026-01-22/amc
Inst Owners81.71%
Inst Owner ChangeN/A
Ins Owners1.69%
Ins Owner ChangeN/A
Market Cap19.73B
Revenue(TTM)7.21B
Net Income(TTM)2.03B
Analysts49.47
Price Target95.49 (5.61%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.96%
Yearly Dividend4.33
Dividend Growth(5Y)10.37%
DP56.29%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.28%
Min EPS beat(2)2.88%
Max EPS beat(2)9.67%
EPS beat(4)3
Avg EPS beat(4)2.48%
Min EPS beat(4)-5.31%
Max EPS beat(4)9.67%
EPS beat(8)6
Avg EPS beat(8)4.37%
EPS beat(12)10
Avg EPS beat(12)5.89%
EPS beat(16)11
Avg EPS beat(16)2.82%
Revenue beat(2)0
Avg Revenue beat(2)-1.66%
Min Revenue beat(2)-2.2%
Max Revenue beat(2)-1.12%
Revenue beat(4)0
Avg Revenue beat(4)-2.66%
Min Revenue beat(4)-4.33%
Max Revenue beat(4)-1.12%
Revenue beat(8)1
Avg Revenue beat(8)-2.88%
Revenue beat(12)2
Avg Revenue beat(12)-2.22%
Revenue beat(16)3
Avg Revenue beat(16)-2.74%
PT rev (1m)-1.8%
PT rev (3m)5.24%
EPS NQ rev (1m)0.18%
EPS NQ rev (3m)6.81%
EPS NY rev (1m)-0.06%
EPS NY rev (3m)5.79%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.99%
Revenue NY rev (1m)0.16%
Revenue NY rev (3m)1.27%
Valuation
Industry RankSector Rank
PE 11.23
Fwd PE 10.1
P/S 3.2
P/FCF 19.7
P/OCF 15.46
P/B 2.13
P/tB 2.92
EV/EBITDA 7.35
EPS(TTM)8.05
EY8.9%
EPS(NY)8.95
Fwd EY9.9%
FCF(TTM)4.59
FCFY5.08%
OCF(TTM)5.85
OCFY6.47%
SpS28.28
BVpS42.44
TBVpS30.92
PEG (NY)1.77
PEG (5Y)4.65
Graham Number87.68
Profitability
Industry RankSector Rank
ROA 13.79%
ROE 18.78%
ROCE 18.12%
ROIC 13.51%
ROICexc 18.68%
ROICexgc 30.26%
OM 32.91%
PM (TTM) 28.18%
GM N/A
FCFM 16.23%
ROA(3y)14.15%
ROA(5y)17.62%
ROE(3y)18.44%
ROE(5y)23.71%
ROIC(3y)15.27%
ROIC(5y)18%
ROICexc(3y)18.71%
ROICexc(5y)21.89%
ROICexgc(3y)30.22%
ROICexgc(5y)33.06%
ROCE(3y)20.58%
ROCE(5y)24.24%
ROICexgc growth 3Y-16.2%
ROICexgc growth 5Y-1.08%
ROICexc growth 3Y-13.37%
ROICexc growth 5Y-6.73%
OM growth 3Y-11.5%
OM growth 5Y-4.63%
PM growth 3Y-9.7%
PM growth 5Y-4.85%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.03
Debt/EBITDA 0.01
Cap/Depr 118.97%
Cap/Sales 4.45%
Interest Coverage 250
Cash Conversion 56.43%
Profit Quality 57.6%
Current Ratio 2.76
Quick Ratio 2.76
Altman-Z 5.81
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)130.91%
Cap/Depr(5y)124.54%
Cap/Sales(3y)4.8%
Cap/Sales(5y)4.19%
Profit Quality(3y)84.47%
Profit Quality(5y)86.86%
High Growth Momentum
Growth
EPS 1Y (TTM)5.26%
EPS 3Y-9.91%
EPS 5Y2.42%
EPS Q2Q%9.34%
EPS Next Y6.35%
EPS Next 2Y5.83%
EPS Next 3Y3.92%
EPS Next 5Y4.23%
Revenue 1Y (TTM)4.26%
Revenue growth 3Y-2.58%
Revenue growth 5Y4.78%
Sales Q2Q%6.04%
Revenue Next Year2.74%
Revenue Next 2Y4.16%
Revenue Next 3Y3.44%
Revenue Next 5Y1.47%
EBIT growth 1Y7.98%
EBIT growth 3Y-13.78%
EBIT growth 5Y-0.07%
EBIT Next Year7.84%
EBIT Next 3Y6.45%
EBIT Next 5Y0.98%
FCF growth 1Y22.49%
FCF growth 3Y-26.76%
FCF growth 5Y-0.86%
OCF growth 1Y20.05%
OCF growth 3Y-21.25%
OCF growth 5Y2.05%

T ROWE PRICE GROUP INC / TR1.DE FAQ

Can you provide the ChartMill fundamental rating for T ROWE PRICE GROUP INC?

ChartMill assigns a fundamental rating of 7 / 10 to TR1.DE.


What is the valuation status of T ROWE PRICE GROUP INC (TR1.DE) stock?

ChartMill assigns a valuation rating of 7 / 10 to T ROWE PRICE GROUP INC (TR1.DE). This can be considered as Undervalued.


Can you provide the profitability details for T ROWE PRICE GROUP INC?

T ROWE PRICE GROUP INC (TR1.DE) has a profitability rating of 6 / 10.


Can you provide the financial health for TR1 stock?

The financial health rating of T ROWE PRICE GROUP INC (TR1.DE) is 9 / 10.


What is the expected EPS growth for T ROWE PRICE GROUP INC (TR1.DE) stock?

The Earnings per Share (EPS) of T ROWE PRICE GROUP INC (TR1.DE) is expected to grow by 6.35% in the next year.